Results 121 to 130 of about 2,758 (199)

Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. [PDF]

J Blood Med
Bienz M, Oliver M, Sperlich C, Patriquin CJ.   +3 more
europepmc   +1 more source

Assessing the Value Contribution of Vyvgart^® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis. [PDF]

Adv Ther
Cortés-Vicente E, Guerrero A, Díaz C, Martínez E, Toja-Camba FJ, Abad MR, Serra JM, Trillo JL, Martín Machín C, Gil A.   +9 more
europepmc   +1 more source

Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria. [PDF]

Agboola, Foluso, Carlson, Josh J, Dickerson, Ronald, Fahim, Shahariar Mohammed, Herce-Hagiwara, Belen, Makam, Anil N, Pearson, Steven D, Richardson, Marina, Suh, Kangho   +8 more
core   +1 more source

C3 mutation-associated atypical hemolytic uremic syndrome with severe renal dysfunction and hypertensive emergency successfully treated with ravulizumab and sacubitril/valsartan: a case report. [PDF]

BMC Nephrol
Yanagidani H, Maeoka Y, Yoshida M, Ueda M, Kumano M, Takahashi A, Okubo A, Kato N, Maruyama S, Masaki T.   +9 more
europepmc   +1 more source

Oral Corticosteroid and Nonsteroidal Immunosuppressant Therapy Use in Patients with Myasthenia Gravis Receiving Ravulizumab, Eculizumab, or Efgartigimod in the USA. [PDF]

Neurol Ther
Saccà F, Lee J, Yee KS, Silvestri NJ, Sabatella G.   +4 more
europepmc   +1 more source

Disease-modifying treatments in paroxysmal nocturnal hemoglobinuria: a systematic review of economic evaluations. [PDF]

Cost Eff Resour Alloc
Moradi S, Khajeamiri Y, Zandi S, Keramati M, Mohammadnezhad G.   +4 more
europepmc   +1 more source

Ravulizumab in the Management of Refractory Myasthenic Crisis: Clinical and Ventilatory Evidence of Early Recovery-A Case Report. [PDF]

Case Rep Neurol Med
Manlio Sgarzi, Paolo Paone, Paolo Gritti, Emanuela Agazzi, Giorgia Camera, Dario Alimonti.   +5 more
europepmc   +1 more source

Ravulizumab in IgA Nephropathy

Journal of the American Society of Nephrology
Gao, Youyuan, Huang, Yunjian
openaire   +3 more sources

Crovalimab Rescue Therapy in a Case With Genetic Complement Mediated Thrombotic Microangiopathy. [PDF]

Kidney Med
Aigner C, Prohászka Z, Szilágyi Á, Böhmig GA, Arbeiter K, Schmidt A, Sunder-Plassmann G.   +6 more
europepmc   +1 more source

Complement Inhibitors in Generalized Myasthenia Gravis: Comparison of Administration Schedules, Efficacy, and Safety. [PDF]

J Clin Med
Di Martino G, Rini N, Bonaventura A, Trovato M, Maccora S, Lima SM, La Seta C, Brighina F, Di Stefano V.   +8 more
europepmc   +1 more source